PCCB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.695400E-01
Normal-vs-Stage2
8.555400E-01
Normal-vs-Stage3
1.996800E-01
Normal-vs-Stage4
3.535600E-01
Stage1-vs-Stage2
2.505800E-02
Stage1-vs-Stage3
6.541500E-02
Stage1-vs-Stage4
1.037560E-01
Stage2-vs-Stage3
1.495440E-01
Stage2-vs-Stage4
2.993800E-01
Stage3-vs-Stage4
7.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.058200E-01
Normal-vs-AfricanAmerican
9.119600E-01
Normal-vs-Asian
7.398800E-01
Caucasian-vs-AfricanAmerican
7.400600E-01
Caucasian-vs-Asian
4.312400E-01
AfricanAmerican-vs-Asian
8.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.543400E-01
Normal-vs-Female
9.125800E-01
Male-vs-Female
1.554650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.715800E-01
Normal-vs-Age(41-60Yrs)
8.849800E-01
Normal-vs-Age(61-80Yrs)
8.437600E-01
Normal-vs-Age(81-100Yrs)
4.178000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.358200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.979800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.865800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.959600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.526000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.382430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.028600E-01
Normal-vs-Daily Drinker
6.153800E-01
Normal-vs-Weekly Drinker
8.463400E-01
Normal-vs-Occasional Drinker
8.510800E-01
Normal-vs-Social Drinker
5.638800E-01
Non Drinker-vs-Daily Drinker
8.858200E-01
Non Drinker-vs-Weekly Drinker
7.149000E-01
Non Drinker-vs-Occasional Drinker
2.722400E-01
Non Drinker-vs-Social Drinker
7.399900E-02
Daily Drinker-vs-Weekly Drinker
6.138200E-01
Daily Drinker-vs-Occasional Drinker
2.409800E-01
Daily Drinker-vs-Social Drinker
5.228400E-02
Weekly Drinker-vs-Occasional Drinker
5.353200E-01
Weekly Drinker-vs-Social Drinker
2.040200E-01
Occasional Drinker-vs-Social Drinker
6.365600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.438600E-01
Normal-vs-Grade 2
9.892200E-02
Normal-vs-Grade 3
1.028850E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.163400E-01
Grade 1-vs-Grade 3
9.512200E-01
Grade 1-vs-Grade 4
2.438600E-01
Grade 2-vs-Grade 3
2.024200E-01
Grade 2-vs-Grade 4
9.892200E-02
Grade 3-vs-Grade 4
1.028850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.712200E-01
Normal-vs-NonDiabetic
9.291600E-01
Diabetic-vs-NonDiabetic
5.455600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.467400E-01
Normal-vs-NoPancreatitis
9.469400E-01
Pancreatitis-vs-NoPancreatitis
7.600400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.434200E-01
Normal-vs-N1
8.159200E-01
N0-vs-N1
1.838830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.943600E-01
Normal-vs-TP53-NonMutant
7.722400E-01
TP53-Mutant-vs-TP53-NonMutant
3.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
